Market Tracker

04/29 5:16pm ET

Regeneron Pharmaceuticals Inc (NASDAQ:REGN)

376.71
Delayed Data
As of Apr 29
 -14.59 / -3.73%
Today’s Change
348.96
Today|||52-Week Range
605.93
-30.61%
Year-to-Date

Today’s Trading

Previous close391.30
Today’s open388.63
Day’s range373.14 - 393.00
Volume889,597
Average volume (3 months)957,143
Market cap$41.1B
Dividend yield--
Data as of 4:00pm ET, 04/29/2016

Growth & Valuation

Earnings growth (last year)+79.80%
Earnings growth (this year)-1.28%
Earnings growth (next 5 years)+17.20%
Revenue growth (last year)+45.55%
P/E ratio68.2
Price/Sales15.24
Price/Book11.20

Competitors

 Today’s
change
Today’s
% change
QQuintiles Transnatio...-0.91-1.30%
ALNYAlnylam Pharmaceutic...-0.84-1.24%
IONSIonis Pharmaceutical...-0.02-0.05%
CRLCharles River Labora...-0.76-0.95%
Data as of 4:01pm ET, 04/29/2016

Financials

Next reporting dateMay 5, 2016
EPS forecast (this quarter)$2.65
Annual revenue (last year)$4.1B
Annual profit (last year)$636.1M
Net profit margin15.50%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Leonard S. Schleifer
Chief Financial Officer &
Senior VP-Finance
Robert E. Landry
Corporate headquarters
Tarrytown, New York

Forecasts